{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:41:11Z","timestamp":1790430071863,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.seizure.2018.06.021","type":"journal-article","created":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T23:08:27Z","timestamp":1530140907000},"page":"198-204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["Electroclinical features of seizures associated with autoimmune encephalitis"],"prefix":"10.1016","volume":"60","author":[{"given":"Claude","family":"Steriade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3123-5713","authenticated-orcid":false,"given":"Ahsan N.V.","family":"Moosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Hantus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Prayson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Alexopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Rae-Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2018.06.021_bib0005","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.seizure.2018.06.021_bib0010","doi-asserted-by":"crossref","first-page":"18161","DOI":"10.1523\/JNEUROSCI.3506-13.2013","article-title":"Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors","volume":"33","author":"Ohkawa","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/j.seizure.2018.06.021_bib0015","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1093\/brain\/awv257","article-title":"Epileptogenic effects of NMDAR antibodies in a passive transfer mouse model","volume":"138","author":"Wright","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.seizure.2018.06.021_bib0020","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/epi.12127","article-title":"Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy","volume":"54","author":"Brenner","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2018.06.021_bib0025","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/epi.12528","article-title":"Investigation of neuronal autoantibodies in two different focal epilepsy syndromes","volume":"55","author":"Ekizoglu","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2018.06.021_bib0030","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/jamaneurol.2016.5429","article-title":"Neurological autoantibody prevalence in epilepsy of unknown etiology","volume":"74","author":"Dubey","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.seizure.2018.06.021_bib0035","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/epi.13797","article-title":"Predictive models in the diagnosis and treatment of autoimmune epilepsy","volume":"58","author":"Dubey","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2018.06.021_bib0040","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1212\/WNL.0000000000000383","article-title":"Utility of an immunotherapy trial in evaluating patients with presumed autoimmune epilepsy","volume":"82","author":"Toledano","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2018.06.021_bib0045","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: position paper of the ILAE commission for classification and terminology","volume":"57","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2018.06.021_bib0050","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/ana.22307","article-title":"Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis","volume":"69","author":"Irani","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.seizure.2018.06.021_bib0055","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1212\/WNL.0b013e3182152808","article-title":"Tonic seizures: a diagnostic clue of anti-LGI1 encephalitis?","volume":"76","author":"Andrade","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2018.06.021_bib0060","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1093\/brain\/aww012","article-title":"Motor cortex and hippocampus are the two main cortical targets in LGI1-antibody encephalitis","volume":"139","author":"Navarro","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.seizure.2018.06.021_bib0065","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1212\/01.wnl.0000276946.08412.ef","article-title":"Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy","volume":"69","author":"Bien","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2018.06.021_bib0070","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00415-014-7540-3","article-title":"Over 10-year follow-up of limbic encephalitis associated with anti-LGI1 antibodies","volume":"262","author":"Agazzi","year":"2015","journal-title":"J Neurol"},{"key":"10.1016\/j.seizure.2018.06.021_bib0075","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1212\/WNL.0000000000003173","article-title":"Anti-LGI1 encephalitis. Clinical syndrome long-term follow-up","volume":"87","author":"Van Sonderen","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2018.06.021_bib0080","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/ene.12529","article-title":"The detection of neural autoantibodies in patients with antiepileptic-drug-resistant epilepsy predicts response to immunotherapy","volume":"22","author":"Iorio","year":"2015","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.seizure.2018.06.021_bib0085","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/epi.14016","article-title":"Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions","volume":"59","author":"Hirsch","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2018.06.021_bib0090","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1001\/archneurol.2011.2985","article-title":"Autoimmune epilepsy. Clinical characteristics and response to immunotherapy","volume":"69","author":"Quek","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.seizure.2018.06.021_bib0095","doi-asserted-by":"crossref","first-page":"e353","DOI":"10.1212\/NXI.0000000000000353","article-title":"Antiepileptic drug therapy in patient with autoimmune epilepsy","volume":"4","author":"Feyissa","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.seizure.2018.06.021_bib0100","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1111\/epi.13436","article-title":"Subclinical temporal EEG seizure pattern in LGI1-antibody-mediated encephalitis","volume":"57","author":"Steriade","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2018.06.021_bib0105","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.seizure.2017.05.017","article-title":"LGI1 antibody encephalitis is characterised by frequent, multifocal clinical and subclinical seizures","volume":"50","author":"Aurangzeb","year":"2017","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2018.06.021_bib0110","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.yebeh.2008.08.008","article-title":"Auditory auras in patients with postencephalitic epilepsy: case series","volume":"14","author":"Bianchi","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2018.06.021_bib0115","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1212\/WNL.56.5.678","article-title":"Chronic encephalitis and temporal lobe epilepsy: a variant of Rasmussen\u2019s syndrome?","volume":"56","author":"Hennessy","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2018.06.021_bib0120","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.yebeh.2013.05.033","article-title":"Extrarolandic electroclinical findings in the evolution of adult-onset Rasmussen\u2019s encephalitis","volume":"28","author":"Casciato","year":"2013","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2018.06.021_bib0125","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1474-4422(13)70260-6","article-title":"Rasmussen\u2019s encephalitis: clinical features, pathobiology, and treatment advances","volume":"13","author":"Varadkar","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.seizure.2018.06.021_bib0130","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1684\/epd.2017.0946","article-title":"Refractory chronic epilepsy associated with neuronal auto-antibodies: could perisylvian semiology be a clue?","volume":"19","author":"Gillinder","year":"2017","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.seizure.2018.06.021_bib0135","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.yebeh.2015.12.041","article-title":"Clinical characterization of autoimmune LGI1 antibody limbic encephalitis","volume":"56","author":"Gao","year":"2016","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2018.06.021_bib0140","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/epi4.12077","article-title":"Claustrum hyperintensities: a potential clue to autoimmune epilepsy","volume":"2","author":"Steriade","year":"2017","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.seizure.2018.06.021_bib0145","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/epi.12968","article-title":"Early and chronic gray matter volume changes in limbic encephalitis revealed by voxel-based morphometry","volume":"56","author":"Wagner","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2018.06.021_bib0150","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1093\/brain\/awm108","article-title":"Ictal clinical and scalp-EEG findings differentiating temporal lobe epilepsies from temporal \u2018plus\u2019 epilepsies","volume":"130","author":"Barba","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.seizure.2018.06.021_bib0155","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/jamaneurol.2016.4226","article-title":"Evaluation of cognitive deficits and structural hippocampal damage in encephalitis with leucine-rich, glioma-inactivated 1 antibodies","volume":"74","author":"Finke","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.seizure.2018.06.021_bib0160","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/brain\/awx070","article-title":"Focal CA3 hippocampal subfield atrophy following LGI1 VGKC-complex antibody limbic encephalitis","volume":"140","author":"Miller","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.seizure.2018.06.021_bib0165","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.eplepsyres.2016.12.010","article-title":"Epilepsy surgery in drug resistant temporal lobe epilepsy associated with neuronal antibodies","volume":"129","author":"Carre\u00f1o","year":"2017","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2018.06.021_bib0170","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/B978-0-444-63432-0.00007-4","article-title":"Neuropathology of autoimmune encephalitides","volume":"133","author":"Bauer","year":"2016","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.seizure.2018.06.021_bib0175","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/epi.12879","article-title":"Postencephalitic epilepsy: clinical characteristics and predictors","volume":"56","author":"Singh","year":"2015","journal-title":"Epilepsia"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131118303054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131118303054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:52:35Z","timestamp":1761011555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131118303054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":35,"alternative-id":["S1059131118303054"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2018.06.021","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Electroclinical features of seizures associated with autoimmune encephalitis","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2018.06.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}